Biomarker Research

Article	Citations
CardioAtlas: deciphering the single-cell transcriptome landscape in cardiovascular tissues and diseases	155
The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma	146
Exosomal PSM-E inhibits macrophage M2 polarization to suppress prostate cancer metastasis through the RACK1 signaling axis	140
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors	130
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients	121
Multiple ctDNA- based biomarkers predict benefit from selective RET Inhibition in non-small cell lung cancer patients: exploratory analysis of a prospective study	120
Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology	109
Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer	102
Mitochondrial transfer in hematological malignancies	101
The spatial impact of a Western diet in enriching Galectin-1-regulated Rho, ECM, and SASP signaling in a novel MASH-HCC mouse model	89
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes	88
Emerging therapeutic agents in multiple myeloma: highlights from the 2024 ASH annual meeting	82
Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma	75
Advances in the DNA methylation hydroxylase TET1	74
Skin-permeable gold nanoparticles with modifications azelamide monoethanolamine ameliorate inflammatory skin diseases	71
A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma	68
Dynamic changes of bone microarchitecture and volumetric mineral density assessed by HR-pQCT in patients with cervical cancer after concurrent chemoradiotherapy: a prospective study	67
Donor T cells for CAR T cell therapy	64
Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC	63
mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends	63
Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer	63
Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions	59
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells	59
The overlooked trio: sleep duration, sampling time and physical exercise alter levels of olink-assessed blood biomarkers of cardiovascular risk	58
p53 biology and reactivation for improved therapy in MDS and AML	57

From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy	56
Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease	54
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients	54
Dysregulation of plasma circulating microRNAs in all-cause and cause-specific cancers: the Rotterdam Study	54
Unveiling the potential of CLL-1: a promising target for AML therapy	54
Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy	54
Multiple regulatory events contribute to a widespread circular RNA downregulation in precancer and early stage of colorectal cancer development	53
Correction: Manipulation of cancer cell pyroptosis for therapeutic approaches: challenges and opportunities	52
The role and metabolic adaptations of neutrophils in premetastatic niches	51
RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages	50
The role of BATF in immune cell differentiation and autoimmune diseases	48
Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics	48
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy	48
STAT3–mediated up-regulation of DAB2 via SRC-YAP1 signaling axis promotes Helicobacter pylori-driven gastric tumorigenesis	48
Oncogenic ACSM6 impairs CD8+ T cell-based immune response in bladder cancer	46
Targeting interleukin-1β and inflammation in lung cancer	46
The involvement of krüppel-like transcription factor 2 in megakaryocytic differentiation induction by phorbol 12-myrestrat 13-acetate	46
Correction: Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation	46
Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas	45
Immunophenotypic analysis on circulating T cells for early diagnosis of lung cancer	45
Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-cell leukemia/lymphoma	45
BRD4: an effective target for organ fibrosis	44
Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma	42
Transcriptomic analysis of transformed small-cell lung cancer from EGFR-mutated lung adenocarcinoma reveals distinct subgroups and precision therapy opportunities	42
Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions	41
Correction: Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation	39
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy	39
Correction: Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential	39
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis	39
Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications	38
The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study	38
Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis	37
Next frontier in tumor immunotherapy: macrophage-mediated immune evasion	37
Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: a meta-analysis	35
Updates on CAR T cell therapy in multiple myeloma	35
Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia	35
Intratumor microbiome in cancer progression: current developments, challenges and future trends	34
Nucleases as molecular targets for cancer diagnosis	34
Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance	34
Current advances and future perspectives on the functional roles and clinical implications of circular RNAs in esophageal squamous cell carcinoma: more influential than expected	34
Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential	33
Fatty acid metabolism shapes immune responses in chronic lymphocytic leukemia	33
Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors	32
MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer	31
Analyzing PKC Gamma (+ 19,506 A/G) polymorphism as a promising genetic marker for HCV-induced hepatocellular carcinoma	31
Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes	30
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer	30
Single-cell RNA sequencing identifies a subtype of FN1 + tumor-associated macrophages associated with glioma recurrence and as a biomarker for immunotherapy	29
High-throughput LDI MS technology decodes the distinct metabolic landscape of prostate cancer in a large-scale cohort	29
Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer	28

The importance of critically short telomere in myelodysplastic syndrome	28
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer	27
Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers	27
Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives	27
Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients	27
Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma	26
Tobacco smoking associates with NF1 mutations exacerbating survival outcomes in gliomas	26
Adipose-derived stem cell exosomes: mechanisms and therapeutic potentials in wound healing	26
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma	26
Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives	26
Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy	26
Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer	25
Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma	25
Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives	24
RNA epigenetic modifications as dynamic biomarkers in cancer: from mechanisms to clinical translation	24
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples	24
NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancer	24
New cell sources for CAR-based immunotherapy	24
A plasma 9-microRNA signature for lung cancer early detection: a multicenter analysis	24
Targeted protein degradation in hematologic malignancies: clinical progression towards novel therapeutics	24
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives	23
Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer	23
FGL1 and FGL2: emerging regulators of liver health and disease	22
Targeting CD47/SIRPα as a therapeutic strategy, where we are and where we are headed	22
Association between circulating ECM-associated molecules and cardiovascular outcomes in hemodialysis patients: a multicenter prospective cohort study	21
Extracellular matrix: unlocking new avenues in cancer treatment	21
METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer	21
Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification	20
T cells in cancer: mechanistic insights and therapeutic advances	20
Association of CAR-T approval on outcomes in patients with diffuse large B-cell lymphoma at the population level in the United States	20
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool	20
S100A9 as a potential novel target for experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome	20
Application of double-negative T cells in haematological malignancies: recent progress and future directions	20
Correction: CRISPR/Cas-based CAR-T cells: production and application	19
HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia	19
Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs	19
EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway	19
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer	18
USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition	18
Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies	18
SRTdb: an omnibus for human tissue and cancer-specific RNA transcripts	18
Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia	18
Targeting TIGIT for cancer immunotherapy: recent advances and future directions	18
The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases	18
MiRNAs as potential therapeutic targets and biomarkers for non-traumatic intracerebral hemorrhage	18
Human induced-T-to-natural killer cells have potent anti-tumour activities	18
Single-cell multi-omics analysis identifies SPP1+ macrophages as key drivers of ferroptosis-mediated fibrosis in ligamentum flavum hypertrophy	18
Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology	18
The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer	17
PCSK9 in T-cell function and the immune response	17
The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications	17
High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma	17
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression	17
Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer	17
Toll-like receptor 3: a double-edged sword	17
A germline FLT3 variant in aplastic anemia	17
Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis	17
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted	17
PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals	16
Noninvasive biomarkers implicated in urea and TCA cycles for metabolic liver disease	16
The significant others of aurora kinase a in cancer: combination is the key	16
Cervical cancer heterogeneity: a constant battle against viruses and drugs	16
Oncogenic alterations in advanced NSCLC: a molecular super-highway	16
Crosstalk between lactylation and RNA modifications in tumorigenesis: mechanisms and therapeutic implications	16
Ribosome profiling: a powerful tool in oncological research	16
The detection, biological function, and liquid biopsy application of extracellular vesicle-associated DNA	15
The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets	15
Blood and urine biomarkers of disease progression in IgA nephropathy	15
LncRNA AC006064.4–201 serves as a novel molecular marker in alleviating cartilage senescence and protecting against osteoarthritis by destabilizing CDKN1B mRNA via interacting with PTBP1	15
The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies	15
Correction: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma	15
MACC1 revisited – an in-depth review of a master of metastasis	14
Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer	14
Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy	14
Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects	14
The role of pyroptosis in modulating the tumor immune microenvironment	14
Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression	14
Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy	13
HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma	13
TRPM channels in human cancers: regulatory mechanism and therapeutic prospects	13

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia	13
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients	13
Vitamin D activates FBP1 to block the Warburg effect and modulate blast metabolism in acute myeloid leukemia	12
Review immune response of targeting CD39 in cancer	12
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation	12
Tumor microenvironment and immunotherapy for triple-negative breast cancer	12
Phenomic landscape and pharmacogenomic implications for HLA region in a Taiwan Han Chinese population	12
Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes	12
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling	12
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma	12
Circulating long non-coding RNAs detection after heart transplantation and its accuracy in the diagnosis of acute cardiac rejection	12
Targeted inhibition of Ninjurin2 promotes chemosensitivity in chemoresistant gastric cancer by suppressing cancer-initiating cells	12
Therapeutic landscape of ovarian cancer: recent advances and emerging therapies	12
Correction: Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements	12
Correction: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer	11
Roles of posttranslational modifications in lipid metabolism and cancer progression	11
Detection of circulating tumor cells: opportunities and challenges	11
Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer	11
Biological roles of RNA m5C modification and its implications in Cancer immunotherapy	11
CRISPR/Cas-based CAR-T cells: production and application	11
Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation	11
Gene therapy for polygenic or complex diseases	11
Clinical stabilization of a highly refractory acute myeloid leukaemia under individualized treatment with immune response modifying drugs by in vivo generation of dendritic cells of leukaemic origin (	11
Sintilimab for the treatment of non-small cell lung cancer	11
CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond	11
Minimal residual disease in multiple myeloma: current status	11
Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies	11
Circulating tumor DNA for MRD detection in colorectal cancer: recent advances and clinical implications	11
Global, regional, and national burden of heart failure and its underlying causes, 1990–2021: results from the global burden of disease study 2021	11
Revolutionizing oncology: the role of Artificial Intelligence (AI) as an antibody design, and optimization tools	11
Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression	10
Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers	10
A functional role of Ephrin type-B receptor 6 (EPHB6) in T-cell acute lymphoblastic leukemia	10
Serum metabolite signatures of cardiac function and morphology in individuals from a population-based cohort	10
LRG1, a novel serum biomarker for iMCD disease activity	10
Correction: A novel 3-miRNA network regulates tumour progression in oral squamous cell carcinoma	10
Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinoma	10
Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia	10
Development and validation of an integrative 54 biomarker-based risk identification model for multi-cancer in 42,666 individuals: a population-based prospective study to guide advanced screening strat	10
DeepMPTB: a vaginal microbiome-based deep neural network as artificial intelligence strategy for efficient preterm birth prediction	10
The war between the immune system and the tumor - using immune biomarkers as tracers	10
Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression	10
Correction: Vitamin D activates FBP1 to block the Warburg effect and modulate blast metabolism in acute myeloid leukemia	10
Combination immunotherapy targeting LAG-3, PD-1 and STING suppresses hepatocellular carcinoma as monitored by LAG-3 targeted PET imaging	10
Global surveillance of circulating microRNA for diagnostic and prognostic assessment of acute myocardial infarction based on the plasma small RNA sequencing	10
Biomarkers as targets for CAR-T/NK cell therapy in AML	10
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma	9
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study	9
Current challenges and best practices for cell-free long RNA biomarker discovery	9
Advances of cancer-associated fibroblasts in liver cancer	9
The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy	9
The telomere complex and the origin of the cancer stem cell	9
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma	9
The application of Aptamer in biomarker discovery	9
Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021	9
Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model	9
Untargeted lipidomics reveals racial differences in lipid species among women	9
Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML	9
A comprehensive comparison between camelid nanobodies and single chain variable fragments	8
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases	8
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective	8
Heat shock proteins (HSPs) in non-alcoholic fatty liver disease (NAFLD): from molecular mechanisms to therapeutic avenues	8
Characterization of T-Cell receptor repertoire in immunoglobulin a nephropathy	8
Advancement in Multi-omics approaches for Uterine Sarcoma	8
Single cell spatial profiling of FFPE splenic tissue from a humanized mouse model of HIV infection	8
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma	8
AXL in myeloid malignancies – an elusive target?	8
Integrating artificial intelligence in drug discovery and early drug development: a transformative approach	8
Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis	8
Bioinformatics tools and data resources for assay development of fluid protein biomarkers	8
The Musashi RNA-binding proteins in female cancers: insights on molecular mechanisms and therapeutic relevance	8
The landscape overview of CD47-based immunotherapy for hematological malignancies	8
Microfluidic biosensors for biomarker detection in body fluids: a key approach for early cancer diagnosis	8
The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy	8
The role of biomarkers in personalized immunotherapy	8
Targeting myeloid cells for hematological malignancies: the present and future	8
KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma	8
Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications	8
X-chromosome-linked miR-542-5p as a key regulator of sex disparity in rats with adjuvant-induced arthritis by promoting Th17 differentiation	7
Single cell analysis identified IFN signaling activation contributes to the pathogenesis of pediatric steroid-sensitive nephrotic syndrome	7
Emerging role of the RNA-editing enzyme ADAR1 in stem cell fate and function	7
Cancer immunotherapy and its facilitation by nanomedicine	7
Development and validation of a predictive model based upon extracellular vesicle-derived transposable elements for non-invasive detection of pancreatic adenocarcinoma	7
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair	7
Lectins as potential tools for cancer biomarker discovery from extracellular vesicles	7
Specific TCR profiles predict clinical outcome of adjuvant EGFR-TKIs for resected EGFR-mutant non-small cell lung cancer	7
CAR-NK cells for cancer immunotherapy: from bench to bedside	7
Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era	7
Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms	7
Insights into genetic aberrations and signalling pathway interactions in chronic lymphocytic leukemia: from pathogenesis to treatment strategies	7
18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tum	7
Novel insights into the role of immunomodulatory extracellular vesicles in the pathogenesis of liver fibrosis	7
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment	7
The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy	7
Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer	7